BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19285601)

  • 1. G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.
    Kim OY; Jo SH; Jang Y; Chae JS; Kim JY; Hyun YJ; Lee JH
    Nutr Res; 2009 Feb; 29(2):106-13. PubMed ID: 19285601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the RAGE affects the serum inflammatory levels and risk of ischemic stroke in a Chinese population.
    Cui X; Chen H; Hou X; Wang S; Jayaram S; Zheng Z
    Cell Physiol Biochem; 2013; 32(4):986-96. PubMed ID: 24107402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.
    Yang L; Wu Q; Li Y; Fan X; Hao Y; Sun H; Cui Y; Han L
    J Diabetes Res; 2013; 2013():264579. PubMed ID: 24303504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.
    Kanikowska D; Kanikowska A; Strojny Z; Kawka E; Zawada A; Rutkowski R; Litwinowicz M; Sato M; Grzymisławski M; Bręborowicz A; Witowski J; Korybalska K
    Cytokine; 2024 Aug; 180():156665. PubMed ID: 38823153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population.
    Gao J; Shao Y; Lai W; Ren H; Xu D
    J Hum Genet; 2010 Oct; 55(10):668-75. PubMed ID: 20668462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
    Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
    Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.
    Kucukhuseyin O; Ozgen T; Karagedik EH; Cesur Y; Yilmaz Aydogan H; Yaylim I; Ergen HA
    Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):9-14. PubMed ID: 27188863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between obesity and RAGE polymorphisms on the risk of knee osteoarthritis in Chinese population.
    Han Z; Liu Q; Sun C; Li Y
    Cell Physiol Biochem; 2012; 30(4):898-904. PubMed ID: 22987041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
    Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
    Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function.
    Kajikawa M; Nakashima A; Fujimura N; Maruhashi T; Iwamoto Y; Iwamoto A; Matsumoto T; Oda N; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Noma K; Takeuchi M; Matsui T; Yamagishi S; Higashi Y
    Diabetes Care; 2015 Jan; 38(1):119-25. PubMed ID: 25336748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.